| scholarly article | Q13442814 |
| P50 | author | Takashi Kojima | Q89451015 |
| P2093 | author name string | Mai Suzuki | |
| Jun Shimazaki | |||
| Murat Dogru | |||
| Yoshiyuki Shibasaki | |||
| Seika Den | |||
| Hiroyuki Iseda | |||
| Naoshi Yoshida | |||
| Megumi Shinzawa | |||
| Cem Simsek | |||
| P2860 | cites work | Down-regulation of Pax6 is associated with abnormal differentiation of corneal epithelial cells in severe ocular surface diseases. | Q33714424 |
| The application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease. | Q33765579 | ||
| Molecular mechanism of proinflammatory cytokine-mediated squamous metaplasia in human corneal epithelial cells | Q33845460 | ||
| A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. | Q34332957 | ||
| Functional aspects of the tear film lipid layer | Q35755125 | ||
| 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications | Q36268036 | ||
| Air exposure induced squamous metaplasia of human limbal epithelium | Q36478497 | ||
| Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye. | Q37139290 | ||
| Topical rebamipide improves lid wiper epitheliopathy | Q37278720 | ||
| Changing trends in the treatment of dry-eye disease | Q38148616 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| Regulation of human corneal epithelial mucins by rebamipide | Q39090645 | ||
| Involvement of Eyelid Pressure in Lid-Wiper Epitheliopathy | Q41389994 | ||
| Ocular cicatricial pemphigoid associated with hyperproliferation of the conjunctival epithelium | Q42455670 | ||
| Rebamipide inhibits tumor necrosis factor-α-induced interleukin-8 expression by suppressing the NF-κB signal pathway in human umbilical vein endothelial cells | Q42979862 | ||
| Prevalence of lid wiper epitheliopathy in subjects with dry eye signs and symptoms. | Q43157174 | ||
| Lid-wiper epitheliopathy and dry-eye symptoms in contact lens wearers | Q44190326 | ||
| Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial | Q44553482 | ||
| Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model | Q44981253 | ||
| The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice | Q45860603 | ||
| A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye. | Q45984720 | ||
| Efficacy of punctum plug treatment in short break-up time dry eye. | Q46447852 | ||
| Mucins and ocular signs in symptomatic and asymptomatic contact lens wear | Q47314621 | ||
| Kinetic Analysis of Tear Interference Images in Aqueous Tear Deficiency Dry Eye before and after Punctal Occlusion | Q47952396 | ||
| Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits. | Q50254467 | ||
| Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study. | Q50490131 | ||
| A quantitative assessment of the location and width of Marx's line along the marginal zone of the human eyelid. | Q51836903 | ||
| Goblet cell density in ocular surface disease. A better indicator than tear mucin. | Q51852207 | ||
| Meibomian orifices and Marx's line. Studied by triple vital staining. | Q53896104 | ||
| Rebamipide increases the mucin-like glycoprotein production in corneal epithelial cells. | Q54324098 | ||
| The Effect of Rebamipide Ophthalmic Solution on Cytokine and Mucin Secretion in Culture of Conjunctival Epithelial Cells From the Cu, Zn-Superoxide Dismutase-1 (SOD-1) Knock-Down Mouse | Q58555895 | ||
| Dry Eye–Induced Conjunctival Epithelial Squamous Metaplasia Is Modulated by Interferon-γ | Q61851323 | ||
| Morphological changes in ocular surface in dry eyes and other disorders by impression cytology | Q68019277 | ||
| Impression cytology | Q68129996 | ||
| Staging of conjunctival squamous metaplasia by impression cytology | Q69906040 | ||
| Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study | Q70248173 | ||
| Conjunctival goblet cell densities in ocular surface disease | Q70367002 | ||
| Possible mechanisms for the loss of goblet cells in mucin-deficient disorders | Q70571012 | ||
| Impression Cytology on Conjunctiva and Cornea in Dry Eye Patients Establishes a Correlation between Squamous Metaplasia and Dry Eye Clinical Severity | Q73273245 | ||
| Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome | Q77846439 | ||
| The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice | Q88293625 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 350-358 | |
| P577 | publication date | 2019-06-28 | |
| P1433 | published in | Journal of Ocular Pharmacology and Therapeutics | Q15755845 |
| P1476 | title | The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease | |
| P478 | volume | 35 |
| Q92703705 | The Effects of Rebamipide 2% Ophthalmic Solution Application on Murine Subbasal Corneal Nerves After Environmental Dry Eye Stress | cites work | P2860 |
Search more.